Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

Danish pharmaceutical company Novo Nordisk has introduced a once-weekly basal insulin injection, Awiqli, which will allow ...

Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly bas ...

PLAINSBORO, N.J., March 26, 2026 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the ...

Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...

Data from the ONWARDS clinical trial program supported the efficacy of once-weekly insulin icodec-abae compared with daily basal insulin. The Food and Drug Administration (FDA) has approved Awiqli ® ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...